First nine months 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.


No votes yet
 
Related
During their visit to the facilities, they have been accompanied by the CEO of ROVI, Juan López-Belmonte; the vice president and CFO,...
2 min
14/05/2021
ROVI achieves an increase of 29% in operating income and 74% in EBITDA
Laboratorios Farmacéuticos Rovi, SA (BME: ROVI), company Pan-European pharmaceutical company specialized and dedicated to the research...
6 min
13/05/2021